TD Asset Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5M | Buy |
539,784
+236,188
| +78% | +$7.68M | 0.02% | 518 |
|
|
2025
Q1 | $11.5M | Sell |
303,596
-30,160
| -9% | -$1.14M | 0.01% | 607 |
|
|
2024
Q4 | $27.3M | Sell |
333,756
-32,400
| -9% | -$2.65M | 0.02% | 436 |
|
|
2024
Q3 | $41.4M | Buy |
366,156
+53,730
| +17% | +$6.08M | 0.04% | 340 |
|
|
2024
Q2 | $23.6M | Buy |
312,426
+31,138
| +11% | +$2.35M | 0.02% | 451 |
|
|
2024
Q1 | $19.2M | Buy |
281,288
+114,252
| +68% | +$7.8M | 0.02% | 498 |
|
|
2023
Q4 | $10.5M | Buy |
167,036
+15,890
| +11% | +$998K | 0.01% | 608 |
|
|
2023
Q3 | $7.71M | Buy |
151,146
+62,101
| +70% | +$3.17M | 0.01% | 633 |
|
|
2023
Q2 | $4.45M | Buy |
89,045
+69,845
| +364% | +$3.49M | 0.01% | 766 |
|
|
2023
Q1 | $720K | Buy |
19,200
+5,644
| +42% | +$212K | ﹤0.01% | 1201 |
|
|
2022
Q4 | $650K | Buy |
+13,556
| New | +$650K | ﹤0.01% | 1230 |
|